Shuttleworth; Stephen J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shuttleworth; Stephen J..The latest application filed is for "tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors".
Company Profile
2.20.22
- Shuttleworth; Stephen J. - Oxfordshire GB
- Shuttleworth; Stephen J. - Abingdon GB
- Shuttleworth; Stephen J. - Slough GB
- Shuttleworth; Stephen J. - Buckinghamshire GB
- Shuttleworth; Stephen J. - Bourne End GB
- Shuttleworth; Stephen J - Berkshire GB
- Shuttleworth; Stephen J. - Berkshire GB
Patent Activity
| Patent | Date |
|---|---|
| Histone deacetylase inhibitors Grant 10,870,624 - Shuttleworth , et al. December 22, 2 | 2020-12-22 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 10,442,815 - Shuttleworth , et al. Oc | 2019-10-15 |
| Histone deacetylase inhibitors and their use in therapy Grant 10,150,763 - Shuttleworth , et al. Dec | 2018-12-11 |
| Compositions Comprising A Pi3k Inhibitor And An Hdac Inhibitor App 20180243317 - Shuttleworth; Stephen J. ; et al. | 2018-08-30 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20180244685 - Shuttleworth; Stephen J. ; et al. | 2018-08-30 |
| Novel Histone Deacetylase Inhibitors App 20180170876 - Shuttleworth; Stephen J. ; et al. | 2018-06-21 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 9,938,290 - Shuttleworth , et al. April 10, 2 | 2018-04-10 |
| Novel Histone Deacetylase Inhibitors And Their Use In Therapy App 20180086750 - Shuttleworth; Stephen J. ; et al. | 2018-03-29 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20180009826 - Shuttleworth; Stephen J. ; et al. | 2018-01-11 |
| Histone deacetylase inhibitors Grant 9,862,685 - Shuttleworth , et al. January 9, 2 | 2018-01-09 |
| Histone deacetylase inhibitors and their use in therapy Grant 9,676,765 - Shuttleworth , et al. June 13, 2 | 2017-06-13 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 9,580,442 - Shuttleworth , et al. February 28, 2 | 2017-02-28 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20160108057 - Shuttleworth; Stephen J. ; et al. | 2016-04-21 |
| Novel Histone Deacetylase Inhibitors App 20160096804 - Shuttleworth; Stephen J. ; et al. | 2016-04-07 |
| Pharmaceutical compounds Grant 8,946,217 - Shuttleworth , et al. February 3, 2 | 2015-02-03 |
| Pharmaceutical Compounds App 20140294946 - Shuttleworth; Stephen J. ; et al. | 2014-10-02 |
| Pharmaceutical Compounds App 20130317017 - Shuttleworth; Stephen J. ; et al. | 2013-11-28 |
| Pharmaceutical Compounds App 20120258966 - Shuttleworth; Stephen J. ; et al. | 2012-10-11 |
| Substituted thieno- and furano- fused pyrimidines as PI3K inhibitors Grant 8,153,639 - Chuckowree , et al. April 10, 2 | 2012-04-10 |
| Pharmaceutical compounds Grant 8,153,629 - Shuttleworth , et al. April 10, 2 | 2012-04-10 |
| Pharmaceutical compounds Grant 8,101,607 - Shuttleworth , et al. January 24, 2 | 2012-01-24 |
| Pharmaceutical compounds Grant 7,872,003 - Shuttleworth , et al. January 18, 2 | 2011-01-18 |
| Pharmaceutical Compounds App 20100280027 - Shuttleworth; Stephen J. ; et al. | 2010-11-04 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,816,367 - Akerman , et al. October 19, 2 | 2010-10-19 |
| Pharmaceutical Compounds App 20100234370 - Shuttleworth; Stephen J. ; et al. | 2010-09-16 |
| Pharmaceutical compounds Grant 7,776,856 - Shuttleworth , et al. August 17, 2 | 2010-08-17 |
| Furanopyrimidines Grant 7,776,867 - Buchanan , et al. August 17, 2 | 2010-08-17 |
| Pharmaceutical compounds Grant 7,750,002 - Shuttleworth , et al. July 6, 2 | 2010-07-06 |
| Pharmaceutical compounds Grant 7,696,204 - McDonald , et al. April 13, 2 | 2010-04-13 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,649,110 - Akerman , et al. January 19, 2 | 2010-01-19 |
| Pharmaceutical Compounds App 20090209559 - Chuckowree; Irina S. ; et al. | 2009-08-20 |
| Substituted benzofused heterocycles Grant 7,572,783 - Chen , et al. August 11, 2 | 2009-08-11 |
| Pyrimidine Derivatives For The Treatment Of Cancer App 20090156601 - McDonald; Edward ; et al. | 2009-06-18 |
| Pharmaceutical Compounds App 20090042884 - McDonald; Edward ; et al. | 2009-02-12 |
| Pharmaceutical compounds App 20080207609 - Shuttleworth; Stephen J. ; et al. | 2008-08-28 |
| Pharmaceutical compounds App 20080207611 - Shuttleworth; Stephen J. ; et al. | 2008-08-28 |
| Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity Grant 7,358,250 - Farthing , et al. April 15, 2 | 2008-04-15 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20070142384 - Akerman; Michelle ; et al. | 2007-06-21 |
| Substituted benzofused heterocycles App 20060199796 - Chen; Xi ; et al. | 2006-09-07 |
| Furanopyrimidines App 20060040961 - Buchanan; John Laird ; et al. | 2006-02-23 |
| Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity App 20060040965 - Farthing; Christopher N. ; et al. | 2006-02-23 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20060004012 - Akerman; Michelle ; et al. | 2006-01-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 